Listening to the news can feel like a journey.

The 1A podcast is here to guide you beyond the headlines and cut through the noise.

Listen to 1A or we celebrate your freedom to listen by getting to the heart of the story together.

Only from NPR.

Hi, this is Julia and Philly. Right now I'm paying my electric bill, wishing I had turned the lights

off more often in my apartment, saving me money and reducing my impact on the environment.

This podcast was recorded at 11.39 a.m. Eastern time on Friday, October 6th of 2023.

Things may have changed by the time you hear this, but I'll still be annoying my roommates by

constantly turning off the lights and leaving them in the dark. Okay, here's the show.

You know, I'm a big turn off the lights person too. It actually really annoys me when my

boys leave the lights on all the time. Well, hey there, it's the NPR Politics podcast. I'm

a Smakhalla that I cover the White House. I'm Ron Elving, Editor Correspondent and I'm Nina

Tottenberg. I cover the Supreme Court. And today on the show, what to watch for in the Supreme

Court's new term. And Nina, since you are with us and since you are obviously our Supreme Court

expert, I want to begin by asking you just a very basic question. What is the biggest case?

Maybe you can't put a singular case number, but what is the single biggest case if you

choose one that you are keeping your eyes on this term? Well, officially the court hasn't said

it's going to hear this case, but it will. And it's the case testing the accessibility of abortion

pills in the United States. And even more broadly, how much courts can or should second guess

the FDA, which for about a, you know, as long as it's been in existence has earned quite a reputation

for being the policeman of how pharmaceuticals are marketed, whether they can be approved,

who gets them, etc. And what's at stake in that case? Is it the widespread accessibility and

...